Tag Autoimmune Disease

AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies, furthering the AstraZeneca cell therapy ambition.

AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing innovative cell therapies for the treatment of cancer and autoimmune diseases, furthering the AstraZeneca cell therapy ambition. The proposed acquisition will enrich AstraZeneca’s…